Fernando Pedro Polack

Possui graduação em medicina pela University of Buenos Aires(1990), ensino-medio-segundo-graupelo Colegio Nacional de Buenos Aires(1985), residencia-medicapela Hospital Frances(1993), residencia-medicapela William Beaumont Hospital(1996) e residencia-medicapela Johns Hopkins University(1999). Atualmente é Membro de comitê assessor da Fundacion INFANT. Tem experiência na área de Medicina.

Informações coletadas do Lattes em 04/11/2022

Acadêmico

Formação acadêmica

Especialização - Residência médica

1996 - 1999

Johns Hopkins University
Residência médica em: Division of Pediatric Infectious Diseases Department of PediatricsNúmero do registro: .

Especialização - Residência médica

1993 - 1996

William Beaumont Hospital
Residência médica em: Department of PediatricsNúmero do registro: .

Especialização - Residência médica

1991 - 1993

Hospital Frances
Residência médica em: Department of PediatricsNúmero do registro: .

Graduação em medicina

1985 - 1990

University of Buenos Aires

Ensino Médio (2º grau)

1982 - 1985

Colegio Nacional de Buenos Aires

Formação complementar

2003 - 2003

Extensão universitária em Diplomat in Pediatrics. , American Board of Pediatrics.

2001 - 2001

Extensão universitária em Diplomat in Pediatric Infectious Diseases. , American Board of Pediatrics.

1996 - 1996

Extensão universitária em Diplomat in Pediatrics. , American Board of Pediatrics.

Idiomas

Inglês

Compreende Bem, Fala Bem, Lê Bem, Escreve Bem.

Espanhol

Compreende Bem, Fala Bem, Lê Bem, Escreve Bem.

Áreas de atuação

Grande área: Ciências da Saúde / Área: Medicina.

Participação em eventos

RSV pathogenesis: from bench to bedside..RSV pathogenesis: from bench to bedside.. 2012. (Outra).

A new public health paradigm for RSV bronchiolitis.A new public health paradigm for RSV bronchiolitis. 2012. (Outra).

Bronchioltis and pregnant women s diet: Too sweet to be good..Bronchioltis and pregnant women s diet: Too sweet to be good.. 2012. (Outra).

A new public health paradigm for RSV bronchiolitis..A new public health paradigm for RSV bronchiolitis.. 2012. (Outra).

Rhinovirus is a severe pathogen for premature babies..Rhinovirus is a severe pathogen for premature babies.. 2012. (Outra).

Human metapneumovirus.Human metapneumovirus. 2011. (Outra).

Bacterial-viral interaction in respiratory diseases.Bacterial-viral interaction in respiratory diseases. 2011. (Outra).

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. 2011. (Outra).

Pandemic influenza: impact in children and insights into pathogenesis.Pandemic influenza: impact in children and insights into pathogenesis. 2010. (Outra).

The burden of past exposures in viral pathogenesis..The burden of past exposures in viral pathogenesis.. 2010. (Outra).

Respiratory syncytial virus pathogenesis. From bench to bedside..Respiratory syncytial virus pathogenesis. From bench to bedside.. 2010. (Outra).

The role of immune complexes in viral pathogenesis..The role of immune complexes in viral pathogenesis.. 2010. (Outra).

Respiratory infections, the burden of the past..Respiratory infections, the burden of the past.. 2010. (Outra).

Preventive role of breastfeeding against respiratory viral infections.Preventive role of breastfeeding against respiratory viral infections. 2010. (Outra).

Pathogenesis of influenza virus in children and middle age adults.Pathogenesis of influenza virus in children and middle age adults. 2010. (Outra).

Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes.Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. 2010. (Outra).

Bacterial-viral interaction in respiratory diseases..Bacterial-viral interaction in respiratory diseases.. 2010. (Outra).

RSV pathogenesis: from bench to bedside..RSV pathogenesis: from bench to bedside.. 2010. (Outra).

A role for IL-17 producing T cells in enhanced RSV disease..A role for IL-17 producing T cells in enhanced RSV disease.. 2010. (Outra).

The complex relationship between RSV and asthma..The complex relationship between RSV and asthma.. 2009. (Outra).

The role of breastfeeding in protection against respiratory diseases..The role of breastfeeding in protection against respiratory diseases.. 2009. (Outra).

Dengue: thinking forward..Dengue: thinking forward.. 2009. (Outra).

Dengue: Thinking forward.Dengue: Thinking forward. 2009. (Outra).

Respiratory syncytial virus pathogenesis. From bench to bedside..Respiratory syncytial virus pathogenesis. From bench to bedside.. 2009. (Outra).

Preventive role of breastfeeding against respiratory viral infections..Preventive role of breastfeeding against respiratory viral infections.. 2009. (Outra).

Bronchiolitis: the role of TLR4 and the immune system in pathogenesis.Bronchiolitis: the role of TLR4 and the immune system in pathogenesis. 2008. (Outra).

Respiratory syncytial virus pathogenesis.Respiratory syncytial virus pathogenesis. 2008. (Outra).

The role of gender on breastfeeding-mediated protection.The role of gender on breastfeeding-mediated protection. 2008. (Outra).

The role of gender on breastfeeding-mediated protection..The role of gender on breastfeeding-mediated protection.. 2008. (Outra).

Respiratory syncytial virus pathogenesis. From bench to bedside.Respiratory syncytial virus pathogenesis. From bench to bedside. 2008. (Outra).

: Respiratory syncytial virus pathogenesis. From bench to bedside.: Respiratory syncytial virus pathogenesis. From bench to bedside. 2008. (Outra).

The role of gender on breastfeeding-mediated protection..The role of gender on breastfeeding-mediated protection.. 2008. (Outra).

Respiratory syncytial virus pathogenesis. From bench to bedside..Respiratory syncytial virus pathogenesis. From bench to bedside.. 2007. (Outra).

Vaccines against respiratory syncytial virus and Impact of respiratory viruses in children.Vaccines against respiratory syncytial virus and Impact of respiratory viruses in children. 2007. (Outra).

Respiratory syncytial virus pathogenesis. From bench to bedside..Respiratory syncytial virus pathogenesis. From bench to bedside.. 2007. (Outra).

Vaccines against respiratory syncytial virus.Vaccines against respiratory syncytial virus. 2007. (Outra).

Respiratory syncytial virus pathogenesis. From bench to bedside..Respiratory syncytial virus pathogenesis. From bench to bedside.. 2007. (Outra).

Development of a translational research program in a developing country.Development of a translational research program in a developing country. 2007. (Outra).

Role of human metapneumovirus in populations at high risk for severe lung disease..Role of human metapneumovirus in populations at high risk for severe lung disease.. 2006. (Outra).

Role of antibody in enhanced diseases due to paramyxoviruses..Role of antibody in enhanced diseases due to paramyxoviruses.. 2006. (Outra).

A rhesus macaque model of atypical measles.A rhesus macaque model of atypical measles. 2006. (Outra).

Respiratory syncytial virus pathogenesis. From bench to bedside..Respiratory syncytial virus pathogenesis. From bench to bedside.. 2006. (Outra).

Respiratory syncytial virus glycoproteins and their role in pulmonary disease..Respiratory syncytial virus glycoproteins and their role in pulmonary disease.. 2006. (Outra).

The human metapneumovirus in infants and young children..The human metapneumovirus in infants and young children.. 2005. (Outra).

Pathogenesis of enhanced respiratory syncytial virus disease: Role of complement, antibody and cellular immunity..Pathogenesis of enhanced respiratory syncytial virus disease: Role of complement, antibody and cellular immunity.. 2005. (Outra).

New Vaccines: From a cow to the bench.New Vaccines: From a cow to the bench. 2005. (Outra).

Respiratory syncytial virus pathogenesis: from bench to bedside..Respiratory syncytial virus pathogenesis: from bench to bedside.. 2005. (Outra).

The human metapneumovirus..The human metapneumovirus.. 2004. (Outra).

Measles virus. Disease potentiation, immune suppression and other problems..Measles virus. Disease potentiation, immune suppression and other problems.. 2004. (Outra).

The role of antibody affinity maturation in atypical measles..The role of antibody affinity maturation in atypical measles.. 2004. (Outra).

Enhanced diseases after vaccination with inactivated vaccines against paramyxoviruses..Enhanced diseases after vaccination with inactivated vaccines against paramyxoviruses.. 2004. (Outra).

The role of complement and antibody in enhanced respiratory syncytial virus disease.The role of complement and antibody in enhanced respiratory syncytial virus disease. 2003. (Outra).

The immune system during RSV infection.The immune system during RSV infection. 2003. (Outra).

The human metapneumovirus.The human metapneumovirus. 2003. (Outra).

The human metapneumovirus..The human metapneumovirus.. 2003. (Outra).

From a cow to the bench: designing vaccines for the 21st century..From a cow to the bench: designing vaccines for the 21st century.. 2003. (Outra).

Respiratory syncytial virus. Mechanisms of illness and genetic predisposition to severe lower respiratory tract disease..Respiratory syncytial virus. Mechanisms of illness and genetic predisposition to severe lower respiratory tract disease.. 2002. (Outra).

Role of affinity maturation in protection mediated by antibody. The atypical measles story..Role of affinity maturation in protection mediated by antibody. The atypical measles story.. 2002. (Outra).

Enhanced respiratory syncytial virus disease..Enhanced respiratory syncytial virus disease.. 2002. (Outra).

From a cow to the bench: designing vaccines for the 21st century..From a cow to the bench: designing vaccines for the 21st century.. 2002. (Outra).

The role of antibodies in enhanced diseases associated with inactivated paramyxovirus vaccines..The role of antibodies in enhanced diseases associated with inactivated paramyxovirus vaccines.. 2001. (Outra).

Atypical measles: antibodies and eosinophils..Atypical measles: antibodies and eosinophils.. 2001. (Outra).

Pathogenesis of atypical measles.Pathogenesis of atypical measles. 1999. (Outra).

Atypical Kawasaki disease..Atypical Kawasaki disease.. 1996. (Outra).

Produções bibliográficas

EK, M. ; J, B. ; R, L. ; BE, S. ; PM, S. ; PL, A. ; D, H. ; N, R. ; JP, B. ; S, C. ; MI, K. ; G, B. ; A, B. ; SR, K. ; POLACK, F. P. . Human rhinoviruses in severe respiratory disease in very low birth weight infants. Academic Pediatrics (Online) , v. 129, p. e60, 2012.
MELENDI, GUILLERMINA A. ; BRIDGET, DOWD ; MONSALVO, ANA C. ; LAHAM, FEDERICO F. ; ACOSTA, PATRICIO ; DELGADO, MARIA FLORENCIA ; POLACK, FERNANDO P. ; IRUSTA, PABLO M. . Conserved cysteine residues within the attachment G glycoprotein of respiratory syncytial virus play a critical role in the enhancement of cytotoxic T-lymphocyte responses. Virus Genes , v. 42, p. 46-54, 2011.
LIBSTER, ROMINA BUGNA, JIMENA COVIELLO, SILVINA HIJANO, DIEGO R. DUNAIEWSKY, MARIANA REYNOSO, NATALIA CAVALIERI, MARIA L. GUGLIELMO, MARIA C. ARESO, M. SOLEDAD GILLIGAN, TOMAS SANTUCHO, FERNANDA CABRAL, GRACIELA GREGORIO, GABRIELA L. MORENO, RINA LUTZ, MARIA I. PANIGASI, ALICIA L. SALIGARI, LILIANA CABALLERO, MAURICIO T. EGÜES ALMEIDA, RODRIGO M. GUTIERREZ MEYER, MARIA E. NEDER, MARIA D. DAVENPORT, MARIA C. DEL VALLE, MARIA P. SANTIDRIAN, VALERIA S. MOSCA, GUILLERMINA , et al. GARCIA DOMÍNGUEZ, MERCEDES ALVAREZ, LILIANA LANDA, PATRICIA POTA, ANA BOLOÑATI, NORMA DALAMON, RICARDO SANCHEZ MERCOL, VICTORIA I. ESPINOZA, MARCO PEUCHOT, JUAN CARLOS KAROLINSKI, ARIEL BRUNO, MIRIAM BORSA, ANA FERRERO, FERNANDO BONINA, ANGEL RAMONET, MARGARITA ALBANO, LIDIA C. LUEDICKE, NORA ALTERMAN, ELIAS SAVY, VILMA BAUMEISTER, ELSA CHAPPELL, JAMES D. EDWARDS, KATHRYN M. MELENDI, GUILLERMINA A. POLACK, FERNANDO P. ; Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1) in Argentina. New England Journal of Medicine (Online) , v. 362, p. 45-55, 2010.
BUGNA, JIMENA ; MORENO, JULIO ; SANCHEZ, SANDRA ; SANCHEZ, ISABEL ; POLACK, FERNANDO P. . Fever and Bleeding in a Newborn Baby. The Pediatric Infectious Disease Journal , v. 29, p. 1153, 2010.
LIBSTER, ROMINA ; COVIELLO, SILVINA ; CAVALIERI, MARIA L. ; MOROSI, ADRIANA ; ALABART, NORA ; ALVAREZ, LILIANA ; FERRERO, FERNANDO ; EDWARDS, KATHRYN M. ; POLACK, FERNANDO P. . Pediatric Hospitalizations Due to Influenza in 2010 in Argentina. New England Journal of Medicine (Online) , v. 363, p. 2472-2473, 2010.
MONSALVO, ANA CLARA BATALLE, JUAN P LOPEZ, M FLORENCIA KRAUSE, JENS C KLEMENC, JENNIFER HERNANDEZ, JOHANNA ZEA MASKIN, BERNARDO BUGNA, JIMENA RUBINSTEIN, CARLOS AGUILAR, LEANDRO DALURZO, LILIANA LIBSTER, ROMINA SAVY, VILMA BAUMEISTER, ELSA AGUILAR, LILIANA CABRAL, GRACIELA FONT, JULIA SOLARI, LILIANA WELLER, KEVIN P JOHNSON, JOYCE ECHAVARRIA, MARCELA EDWARDS, KATHRYN M CHAPPELL, JAMES D CROWE, JAMES E WILLIAMS, JOHN V , et al. MELENDI, GUILLERMINA A POLACK, FERNANDO P ; Severe pandemic 2009 H1N1 influenza disease due to pathogenic immune complexes. Nature Medicine (Online) , v. 17, p. 195-199, 2010.
CHO, HYE-YOUN ; IMANI, FARHAD ; MILLER-DEGRAFF, LAURA ; WALTERS, DIANNE ; MELENDI, GUILLERMINA A. ; YAMAMOTO, MASAYUKI ; POLACK, FERNANDO P. ; KLEEBERGER, STEVEN R. . Antiviral Activity of Nrf2 in a Murine Model of Respiratory Syncytial Virus Disease. American Journal of Respiratory and Critical Care Medicine , v. 179, p. 138-150, 2009.
MF, D. ; S, C. ; AC, M. ; GA, M. ; JZ, H. ; JP, B. ; L, D. ; A, T. ; H-Y, C. ; W, M. ; J, R. ; JA, M. ; PM, I. ; POLACK, F. P. . Lack of antibody affinity maturation due to poor Toll stimulation led to enhanced RSV disease. Nature Medicine (Print) , v. 14, p. 34, 2009.
GA, M. ; S, C. ; N, B. ; JZ, H. ; FEROLLA F, M. ; POLACK, F. P. . Breastfeeding is associated with production of type I interferon in infants infected with influenza virus. Acta Paediatrica (Oslo) , v. 5, p. 3, 2009.
MI, K. ; S, C. ; G, B. ; E, B. ; A, B. ; ME, S. ; MF, D. ; MP, S. ; GA, M. ; N, A. ; PM, I. ; S, R. ; SR, K. ; POLACK, F. P. . Differential gender response to the protective effect of breast milk.. Academic Pediatrics (Print) , v. 121, p. e1510, 2008.
CH, P. ; N, N. ; RJ, A. ; MC, Z. ; EY, L. ; POLACK, F. P. ; M, S. ; DT, O. ; DE, G. . Dose-dependent protection or exacerbation of disease by a PLG microparticle-adsorbed, alphavirus-based measles DNA vaccine in rhesus macaques.. Clinical and Vaccine Immunology , v. 15, p. 214, 2008.
GA, M. ; FR, L. ; AC, M. ; JM, C. ; V, I. ; NR, P. ; SR, K. ; POLACK, F. P. . Virus-specific cytokine signatures in the respiratory tract during primary infection. Academic Pediatrics (Print) , v. 120, p. e410, 2007.
GA, M. ; SJ, H. ; RA, K. ; PM, I. ; FR, L. ; A, H. ; B, S. ; CH, P. ; R, R. ; B, T. ; A, T. ; NP, G. ; W, M. ; SR, B. ; C, G. ; SR, K. ; POLACK, F. P. . C5 modulates airways hyperreactivity and pulmonary eosinophilia during enhanced respiratory syncytial virus disease by decreasing C3a receptor expression. Journal of Medical Virology , v. 81, p. 991, 2007.
GA, M. ; F, Z. ; UJ, B. ; PL, C. ; SR, K. ; POLACK, F. P. . Mapping and characterization of the primary and anamnestic H-2d restricted cytotoxic T lymphocyte response against human metapneumovirus. Journal of Medical Virology , v. 81, p. 11461, 2007.
POLACK, FERNANDO P . Atypical Measles and Enhanced Respiratory Syncytial Virus Disease (ERD) Made Simple. Pediatric Research , v. 62, p. 111-115, 2007.
PASETTI, M F ; RESENDIZ-ALBOR, A ; RAMIREZ, K ; STOUT, R ; PAPANIA, M ; ADAMS, R J ; POLACK, F P ; WARD, B J ; BURT, D ; CHABOT, S ; ULMER, J ; BARRY, E M ; LEVINE, M M . Heterologous Prime-Boost Strategy to Immunize Very Young Infants against Measles: Pre-clinical Studies in Rhesus Macaques. Clinical Pharmacology and Therapeutics , v. 82, p. 672-685, 2007.
MI, K. ; S, C. ; G, B. ; A, B. ; ME, S. ; MP, S. ; MF, D. ; GA, M. ; L, N. ; PENA H, G. ; RA, K. ; SR, K. ; POLACK, F. P. . The impact of infection with human metapneumovirus and other respiratory viruses in young infants and children at high risk for severe pulmonary disease.. J Infect Dis , v. 193, p. 1544, 2006.
A, B. ; ME, S. ; FR, L. ; GA, M. ; SR, K. ; PL, C. ; POLACK, F. P. . The cysteine-rich region and secreted form of the attachment G glycoprotein of respiratory syncytial virus enhance the cytotoxic T lymphocyte response despite lacking MHC class I-restricted epitopes.. Journal of Medical Virology , v. 80, p. 5854, 2006.
RA, K. ; PF, W. ; RB, B. ; B, T. ; R, C. ; F, N. ; POLACK, F. P. ; VB, R. ; A, D. ; J, H. ; W, G. ; BR, M. ; PL, C. . Identification of a recombinant live attenuated respiratory syncytial virus vaccine candidate that is highly attenuated in infants. J Infect Dis , v. 191, p. 1093, 2005.
COVIELLO, SILVINA ; POLACK, FERNANDO . Prophylactic and Therapeutic Approaches Against Respiratory Syncytial Virus. Current Medicinal Chemistry -Anti-Infective Agents , v. 4, p. 67-73, 2005.
CH, P. ; A, V. ; T, C. ; N, N. ; RJ, A. ; POLACK, F. P. ; CE, G. ; S, P. ; JM, P. ; DE, G. . Modulation of disease, T cell responses and measles virus clearance in monkeys vaccinated with H-encoding alphavirus replicon particles.. Proc Natl Acad Sci , v. 102, p. 11581, 2005.
POLACK, F. P. ; PM, I. ; SJ, H. ; MP, S. ; GA, M. ; MF, D. ; FR, L. ; B, T. ; RM, H. ; JA, M. ; RA, K. ; PL, C. ; SR, K. . The cysteine-rich region of respiratory syncytial virus attachment protein inhibits innate immunity elicited by the virus and endotoxin.. Proc Natl Acad Sci , v. 102, p. 8996, 2005.
FR, L. ; V, I. ; JM, C. ; AM, G. ; CM, L. P. ; SJ, H. ; D, H. ; B, T. ; MI, N. ; A, P. ; A, T. ; MT, I. ; M, B. ; M, M. ; RA, G. ; RA, K. ; NR, P. ; POLACK, F. P. . Differential production of inflammatory cytokines between primary infection with human metapneumovirus and other common respiratory viruses of infancy. J Infect Dis , v. 189, p. 2047, 2004.
POLACK, FERNANDO P. ; KARRON, RUTH A. . The future of respiratory syncytial virus vaccine development. The Pediatric Infectious Disease Journal , v. 23, p. S65-S73, 2004.
SR, P. ; SA, K. ; KG, M. ; WK, K. ; DA, G. ; MA, L. ; KC, W. ; JE, S. ; KA, R. ; MK, A. ; POLACK, F. P. ; DE, G. ; NL, L. . Limited contribution of humoral immunity to the clearance of measles viremia in rhesus monkeys.. J Infect Dis , v. 190, p. 998, 2004.
HOFFMAN, SCOTT J. ; LAHAM, FEDERICO R. ; POLACK, FERNANDO P. . Mechanisms of illness during respiratory syncytial virus infection: the lungs, the virus and the immune response. Microbes and Infection , v. 6, p. 767-772, 2004.
ME, S. ; R, W. ; POLACK, F. P. . The human metapneumovirus: what impact on your patients?. Contemporary Peds , v. 25, p. 18, 2004.
DELGADO, M FLORENCIA ; POLACK, FERNANDO P . Involvement of antibody, complement and cellular immunity in the pathogenesis of enhanced respiratory syncytial virus disease. Expert Review of Vaccines , v. 3, p. 693-700, 2004.
POLACK, F. P. ; SJ, H. ; WJ, M. ; DE, G. . Cytokine responses to measles virus challenge after priming with measles DNA vaccines encoding the hemagglutinin and/or fusion protein.. J Infect Dis , v. 187, p. 1794, 2003.
SR, P. ; SA, K. ; KG, M. ; WK, K. ; DA, G. ; MA, L. ; KC, W. ; JE, S. ; KA, R. ; MK, A. ; POLACK, F. P. ; DE, G. ; NL, L. . Role of CD8(+) lymphocytes in control and clearance of measles virus infection of rhesus monkeys. INDIAN J VIROL , v. 77, p. 4396, 2003.
POLACK, FERNANDO P ; HOFFMAN, SCOTT J ; CRUJEIRAS, GONZALO ; GRIFFIN, DIANE E . A role for nonprotective complement-fixing antibodies with low avidity for measles virus in atypical measles. Nature Medicine (Print) , v. 9, p. 1209-1213, 2003.
SJ, H. ; POLACK, F. P. ; D, H. ; M, B. ; M, S. ; DE, G. . Vaccination of rhesus macaques with a recombinant measles virus expressing interleukin-12 alters humoral and cellular immune responses.. J Infect Dis , v. 188, p. 1553, 2003.
HOFFMAN, SCOTT J. ; POLACK, FERNANDO P. ; HAUER, DEBRA A. ; GRIFFIN, DIANE E. . Measles Virus Infection of Rhesus Macaques Affects Neutrophil Expression of IL-12 and IL-10. Viral Immunology , v. 16, p. 369-379, 2003.
POLACK, F. P. ; SJ, H. ; WJ, M. ; DE, G. . Altered synthesis of interleukin-12, type 1 and type 2 cytokines in rhesus macaques during measles and atypical measles.. J Infect Dis , v. 15, p. 13, 2002.
POLACK, F. P. ; TENG, M. N. ; L.COLLINS, P. ; PRINCE, G. A. ; EXNER, M. ; REGELE, H. ; LIRMAN, D. D. ; RABOLD, R. ; HOFFMAN, S. J. ; KARP, C. L. ; KLEEBERGER, S. R. ; WILLS-KARP, M. ; KARRON, R. A. . A Role for Immune Complexes in Enhanced Respiratory Syncytial Virus Disease. Journal of Experimental Medicine , v. 196, p. 859-865, 2002.
MOSS, WILLIAM J. ; POLACK, FERNANDO P. . Immune Responses to Measles and Measles Vaccine: Challenges for Measles Control. Viral Immunology , v. 14, p. 297-309, 2001.
POLACK, F. P. ; DC, F. ; MA, Z. ; JD, D. ; RE, W. . Colonization and antibiotic resistance of Streptococcus pneumoniae in children infected with the human immunodeficiency virus.. Journal of Pediatric Infectious Diseases , v. 19, p. 608, 2000.
GRIFFIN, DIANE E. ; POLACK, FERNANDO P. ; LEE, SOK H. ; PERMAR, SALLIE ; MANYARA, ELIZABETH ; NOUSARI, HOSSEIN G. ; JENG, YAIKAH ; MUSTAFA, FARAH ; VALSAMAKIS, ALEXANDRA ; ADAMS, ROBERT J. ; ROBINSON, HARRIET L. . DNA vaccines against measles virus: Protection associated with neutralizing antibodies against either the H or F protein in the absence of atypical measles.. Nature Medicine (Print) , v. 6, p. 776-781, 2000.
POLACK, F. P. ; N, K. ; MJ, M. . Changing formulas. The dance of infant formula changes.. Clinica Pediatrica (Bologna) , v. 38, p. 703, 1999.
GRIFFIN, DIANE E. ; POLACK, FERNANDO P. ; AUWAERTER, PAUL G. ; LEE, SOK-H. ; NOUSARI, HOSSEIN C. ; VALSAMAKIS, ALEXANDRA ; LEIFERMAN, KRISTIN M. ; DIWAN, ARWIND ; ADAMS, ROBERT J. . Atypical measles: evidence for disease mediated by immune complex formation and eosinophils in the presence of fusion inhibiting antibodies.. Nature Medicine (Print) , v. 5, p. 629-634, 1999.
RE, W. ; POLACK, F. P. . What's new in meningitis in children?. Patient Care (Cessou em 2007) , v. 33, p. 237, 1999.
POLACK, F. P. ; M, C. ; R, R. ; RA, G. ; NR, P. . Infected stingray injury.. Journal of Pediatric Infectious Diseases , v. 17, p. 349, 1998.
POLACK, F. P. ; S, H. ; JA, W. ; W, M. ; RE, W. . Recurrent Francisella philomiragia in chronic granulornatous disease. Journal of Pediatric Infectious Diseases , v. 17, p. 442, 1998.
RE, W. ; POLACK, F. P. . Meningitis in Children. Contemporary Pediatrics (Montvale, N.J.) , v. 15, p. 49, 1998.
POLACK, F. P. ; BJ, F. . Atypical Kawasaki disease in infants: clinical and laboratory manifestations.. Archivos Argentinos de Pediatría , v. 95, p. 39, 1997.
POLACK, F. P. ; DJ, T. ; WM, B. ; BJ, F. ; DJ, A. . Transient elevation of sweat chloride concentration in a malnourished girl with the Mauriac syndrome.. European Journal of Pediatric Dentistry , v. 126, p. 261, 1995.
POLACK, F. P. ; PC, T. ; MV, V. ; NR, P. . Pediatric Crohn's disease in an adolescent.. Archivos Argentinos de Pediatría , v. 91, p. 303, 1993.

Projetos de pesquisa

2012 - Atual

Burden of primary dengue in young infants in Northern Argentina., Descrição: Principal Investigator. Burden of primary dengue in young infants in Northern Argentina. The UBS Optimus Foundation. Total direct cost: $930,000. Current year cost: $310,000.. , Situação: Em andamento; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador.
2011 - 2014

The role of human milk donor banks in pulmonary diseases of prematurity., Descrição: Principal Investigator. The role of human milk donor banks in pulmonary diseases of prematurity. The Thrasher Research Fund. Total direct cost: $550,000. Effort: 20%. Current year cost: $192,000. , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador.
2011 - 2013

Burden of illness of RSV disease, Descrição: Principal Investigator. Burden of illness of RSV disease. Bill & Melinda Gates Foundation. Total direct cost: $1,500,000. Effort: 40% Current year cost: $500,000 . , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador.
2010 - 2011

Identify breast milk components that promote production of type I interferons against RSV and influenza virus infections in the upper respiratory tract, Descrição: Principal Investigator, Abbott Nutrition. Identify breast milk components that promote production of type I interferons against RSV and influenza virus infections in the upper respiratory tract.. Total direct cost: $140,000. Current year direct cost: $80,000.. , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador.
2008 - 2013

Translational Research Program on Pediatric Respiratory Diseases, SeCyT , Argentinean Ministry of Health, Descrição: Principal Investigator, Translational Research Program on Pediatric Respiratory Diseases, SeCyT (Secretary of Health and Technology), Argentinean Ministry of Health, Total direct cost: $582,000. Research Activities . , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador.
2008 - 2011

Understanding dengue hemorrhagic fever., Descrição: Principal Investigator, UBS/ Optimus Foundation. Understanding dengue hemorrhagic fever. Total direct cost: $570,000. Current year direct cost: $190,000.. , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador.
2007 - 2012

Role of antioxidant genes in debilitating diseases in very low birth weight infants, Descrição: Principal Investigator. National Institute of Environmental Health Sciences, NIH. Director´s Challenge. Role of antioxidant genes in debilitating diseases in very low birth weight infants (Buenos Aires, Argentina). Total direct cost: $1,075,000. Current year direct cost: $215,000. Percent effort: 25%. , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador.
2007 - 2009

The role of human metapneumovirus in asthmatic exacerbations in pediatric patients., Descrição: Principal Investigator, Thrasher Research Fund. The role of human metapneumovirus in asthmatic exacerbations in pediatric patients. Total direct cost: $399,000. Current year direct cost: $199,500. Effort: 10% . , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador.
2005 - 2010

Pathogenesis of enhanced respiratory syncytial virus disease., Descrição: Principal Investigator. R01AI54952. Pathogenesis of enhanced respiratory syncytial virus disease. Total direct cost: $1,125,000. Current year direct cost: $225,000. NIAID, National Institutes of Health. Effort: 50%.. , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador.
2004 - 2007

Development of a rhesus macaque model of dengue hemorrhagic fever, Descrição: Co-Investigator. Bill & Melinda Gates Foundation. Development of a rhesus macaque model of dengue hemorrhagic fever. Principal Investigator: Anna Durbin, MD. Effort: 5%. , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador / Anna Durbin - Integrante.
2004 - 2005

Pathogenesis of enhanced respiratory syncytial virus disease., Descrição: Principal Investigator. R21AI54952. Pathogenesis of enhanced respiratory syncytial virus disease. Total direct cost: $225,000 Current year direct cost: $225,000. NIAID, National Institutes of Health. Effort: 50%.. , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador.
2003 - 2006

Role of innate immunity in severity of RSV disease in infants, Descrição: Principal Investigator. Role of innate immunity in severity of RSV disease in infants (Buenos Aires, Argentina). Total direct cost: $544,000. Current year direct cost: $297,000. Percent effort: 25%. , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador.
1999 - 2005

Phase 1 testing of respiratory virus vaccines., Descrição: Co-Investigator. N01AI15444. Phase 1 testing of respiratory virus vaccines. Principal Investigator: Ruth A. Karron, MD. NIAID, National Institutes of Health. Effort: 10%. , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador / Ruth A. Karron - Integrante.
1999 - 2004

Development of a measles vaccine for infants., Descrição: Co-Investigator. Bill & Melinda Gates Foundation. Development of a measles vaccine for infants. Principal Investigator: Diane E. Griffin, PhD. Effort: 5% . , Situação: Concluído; Natureza: Pesquisa. , Integrantes: Fernando Pedro Polack - Coordenador / Diane E. Griffin - Integrante.

Prêmios

2013

Member, American Pediatric Society.

2013

Young Ambassador, American Society for Microbiology, USA..

2012

Doctor Honoris Causa, Universidad Peruana Antenor Orrego de Trujillo, Peru.

2011

Member, American Society for Clinical Investigation.

2011

Bunge & Born Recognition Award, Buenos Aires, Argentina.

2010

E. Mead Johnson Award for Excellence in Pediatric Research., Society for Pediatric Research.

2010

Scholarship award to attend "2nd Summer Institute in Statistics and Modeling in Infectious Diseases"., University of Washington.Seattle, USA.

2010

Fogarty International Clinical Research Fellows Program Award., National Institutes of Health.

2009

Personalidad Destacada de la Ciencia ( Distinguished Citizen in the Field of Sciences ) de la Ciudad de Buenos Aires, Buenos Aires Legislature, Argentina.

2009

Materno-fetal transmission of dengue virus in NE Argentina., Fogarty Early Training Grant, NIH..

2009

Seroepidemiology of dengue virus type 1 and 3 in NE and NW Argentinean infants, Arturo Onativia Ministry of Health Award, Argentina..

2009

Cesar Milstein Endowed Chair in Pediatric Immunology, Vanderbilt University, Nashville, Tennessee.

2008

The role of type I interferon in severe pediatric influenza, Early Career Thrasher Award, Thrasher Foundation.

2008

Differential gender response to the protective effect of breast milk., Luis Pasteur Award, National Academy of Medicine, Argentina..

2008

Luis Pasteur Award, National Academy of Medicine, Argentina.

2006

The preventive role of breastfeeding in rehospitalization of very low birth weight infants with acute lower respiratory infection., INFANT Foundation.

2006

Evaluation of low dose influenza vaccine in infants and young children., Bauerschmidt Research Award.

2006

Young Investigator Award, Society for Pediatric Research.

2005

The preventive role of breastfeeding in rehospitalization of very low birth weight infants with acute lower respiratory infection., INFANT Foundation.

2005

American Academy of Pediatrics Research Award, Jackson Memorial.

2005

The role of human rhinovirus in asthmatic exacerbations, Infectious Diseases Society MedImmune Award.

2004

International Fellowship Award from American Society for Microbiology., INFANT Foundation.

2001

The Thomas and Carol McCann Award in Innovative Respiratory Research, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

1998

Infectious Diseases Society of America, Pasteur Mèrieux Connaught Laboratories Fellowship in Pediatrics.

1997

Harriet Lane House Staff Recognition Award, Department of Pediatrics, The Johns Hopkins Hospital, Baltimore, Maryland.

1995

House Staff Representative, Research Institute Board of Governors, William Beaumont Hospital, Royal Oak, Michigan.

1990

Graduated with Honors, University of Buenos Aires, Argentina..

Histórico profissional

Endereço profissional

Vanderbilt University. , 21st Ave, Garland Ave, 37232 - Nashville, - Estados Unidos, Telefone: (615) 9367852

Experiência profissional

2010 - 2011

Abbott Nutrition

Vínculo: , Enquadramento Funcional:

2010 - 2010

NHRMC

Vínculo: Membro de comitê assessor, Enquadramento Funcional:

Outras informações:
NHRMC, Australia, Reviewer, Project Grant Application.

2009 - 2011

Vanderbilt University

Vínculo: Professor Visitante, Enquadramento Funcional: Associate Professor, Cesar Milstein Chair

Outras informações:
2009-2011 Associate Professor, Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University, Nashville, Tennessee. 2009- Cesar Milstein Chair, Vanderbilt Vaccine Center, Vanderbilt University, Nashville, Tennessee. 2011- Professor, Division of Infectious Diseases, Department of Pediatrics, Vanderbilt University, Nashville, Tennessee.

2009 - 2009

Burroughs Wellcome Foundation

Vínculo: Membro de comitê assessor, Enquadramento Funcional:

Outras informações:
Reviewer, Burroughs Wellcome Foundation, UK

2009 - 2009

National Institutes Of Health

Vínculo: Membro de comitê assessor, Enquadramento Funcional:

Outras informações:
Reviewer, Special Challenge Awards, NIAID, National Institutes of Health, Bethesda, MD.

2009 - 2009

National Institutes Of Health

Vínculo: Membro de comitê assessor, Enquadramento Funcional:

Outras informações:
Study Section, Partnerships for Development of Vaccines for Selected Pathogens, NIAID, National Institutes of Health, Bethesda, MD.

2008 - 2013

Secretary of Health and Technology

Vínculo: , Enquadramento Funcional:

2008 - 2011

Optimus Foundation

Vínculo: , Enquadramento Funcional:

2007 - 2009

Thrasher Research Fund

Vínculo: , Enquadramento Funcional:

2007 - 2007

Conicet

Vínculo: Membro de comitê assessor, Enquadramento Funcional:

Outras informações:
Advisor, Medical Science Committee

2007 - 2007

Conicet

Vínculo: Membro de comitê assessor, Enquadramento Funcional:

Outras informações:
Member, Medical Science Committee, CONICET, Argentina

2007 - 2007

Thrasher Research Fund

Vínculo: Membro de comitê assessor, Enquadramento Funcional:

Outras informações:
Reviewer, Thrasher Research Fund, Salt Lake City, Utah

2007 - 2007

Georgetown University

Vínculo: Professor Visitante, Enquadramento Funcional: Co-Director

Outras informações:
Co-Director. Translational Health Science Internship in Argentina. Georgetown University.

2005 - 2005

World Health Organization

Vínculo: Membro de comitê assessor, Enquadramento Funcional:

Outras informações:
Temporary Advisor, World Health Organization, Healthy Environments for Healthy Children Initiative, Buenos Aires, Argentina

2004 - 2004

American Academy of Pediatrics

Vínculo: Membro de comitê assessor, Enquadramento Funcional:

Outras informações:
Ad-Hoc Reviewer. 27th Red Book

2004 - 2004

Secretary of Foreign Affairs

Vínculo: Membro de comitê assessor, Enquadramento Funcional:

Outras informações:
Reviewer. Public Health Grants

2003 - 2003

INFANT Foundation

Vínculo: Professor Visitante, Enquadramento Funcional: Scientific Director

Outras informações:
Director, INFANT Foundation, Buenos Aires, Argentina.

2003 - Atual

Fundacion INFANT

Vínculo: Membro de comitê assessor, Enquadramento Funcional:

Outras informações:
Executive Director

1999 - 2003

The Johns Hopkins University

Vínculo: Professor Visitante, Enquadramento Funcional: Pediatric Infectious Disease Lecture Series

Outras informações:
Pediatric Infectious Disease Lecture Series for Pediatric Residents. Mon-Thurs discussion of common infectious disease problems encountered during pediatric practice. Department of Pediatrics. Johns Hopkins University.

1999 - 2005

National Institutes Of Health

Vínculo: , Enquadramento Funcional:

1999 - 2004

Bill & Melinda Gates Foundation

Vínculo: , Enquadramento Funcional:

1999 - 2008

Johns Hopkins University

Vínculo: Servidor Público, Enquadramento Funcional: Attending Physician. Pediatric Infectious